NeuroBo Pharmaceuticals Inc

NASDAQ:NRBO  
3.07
-0.12 (-3.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

NeuroBo Pharmaceuticals Inc Stock, NASDAQ:NRBO

200 Berkeley Street, 19th floor, Boston, Massachusetts 02116
United States of America
Phone: +1.857.702.9600
Number of Employees: 7

Description

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline include ANA001, a proprietary oral niclosamide formulation; Gemcabene, which is assessed as an acute indication for COVID-19; NB-01, a treatment for painful diabetic neuropathy; and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Boston, MA.